chevron_leftBack
As of 13 June 2026, BASKHANBIOPharma Inc. has a market cap of $15.69M USD, ranking #38678 globally and #2452 in South Korea.
It ranks #3451 in the Healthcare sector, and #1135 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$15.69MUSD
23.86B KRW
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 2.8% | -5.5% | -27% | -7.9% | -29% | -23% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
354390
주식회사 바스칸바이오제약
ISIN: KR7354390007
Shares Out.:
Shares Outstanding:
7.018M1
Shares Float:
6.152M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3,495 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
58K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
43K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
33K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
32K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
29K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
28K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
5M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
3M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
2M%
|
97.4
|
|
SIX: RO
|
$321.52B
2M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
2M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
2M%
218.9B CHF
|
20.5
|
chevron_leftBack